2013
DOI: 10.1016/j.tetasy.2013.09.015
|View full text |Cite
|
Sign up to set email alerts
|

Preparative access to medicinal chemistry related chiral alcohols using carbonyl reductase technology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
13
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(13 citation statements)
references
References 35 publications
0
13
0
Order By: Relevance
“…High cis , cis -selectivity (>99%) and high enantioselectivity are observed (Scheme 29). Given the remarkable ADH active site plasticity that has already been observed, [15a] and the power of directed evolution, [7c, 12b, 23a] a menu of such biocatalytic transformations may well be forthcoming in the not-too-distant future, in which ‘double, dynamic reductive kinetic resolutions’ are achieved, setting two different dynamic centers, while selectively reducing a central carbonyl functionality, all in a single operation.…”
Section: Future Challengesmentioning
confidence: 99%
See 1 more Smart Citation
“…High cis , cis -selectivity (>99%) and high enantioselectivity are observed (Scheme 29). Given the remarkable ADH active site plasticity that has already been observed, [15a] and the power of directed evolution, [7c, 12b, 23a] a menu of such biocatalytic transformations may well be forthcoming in the not-too-distant future, in which ‘double, dynamic reductive kinetic resolutions’ are achieved, setting two different dynamic centers, while selectively reducing a central carbonyl functionality, all in a single operation.…”
Section: Future Challengesmentioning
confidence: 99%
“…The reader is also pointed to other reviews on dehydrogenase enzymes that may be of interest. [12] Our own interest in dehydrogenase enzymes stems from their utility as “reporting enzymes” in a method for catalyst discovery that we have developed known as In Situ Enzymatic Screening (ISES). [13] In this approach, an alcohol dehydrogenase (ADH) oxidizes the alcoholic product or byproduct of a reaction of interest.…”
Section: Introductionmentioning
confidence: 99%
“…Within the Green Chemistry methodologies, it's possible to emphasize the biocatalysis that can be defined in general as the use of enzymes, whole cells of microorganisms or plants (Vandenberghe et al, 2013). These enzymes sources are biocatalysts in organic synthesis, a very desirable use due to the attractive characteristics of biocatalysis, such as its high selectivity, which can be chemo, regio and stereoselective providing the reduction or elimination of the use of protective groups and simplifying separation processes that can be performed under mild conditions of temperature and pressure, with consequent reduction of costs and waste (Carvalho, 2011;Clouthier and Pelletier, 2012) Among the various biocatalytic reactions we can highlight the bioreductions of prochiral carbonyl groups, these reactions generate chiral alcohols, which are start materials widely used in the synthesis of drugs, flavorings, essences and agricultural products (Ni and Xu, 2012;Rowan, 2013). The chiral alcohol menthol is the major compound followed by its carbonyl derivatives of the essential oil of the plant Mentha piperita L., popularly known as mint.…”
Section: Introductionmentioning
confidence: 99%
“…Chirality is a key factor in the safety and efficacy of many drugs and thus the production of enantiopure drugs has become increasingly important in the pharmaceutical industry. 1 Chiral aromatic secondary alcohols are widely used in synthetic organic and medicinal chemistry as key intermediates for the synthesis of various pharmaceutical products such as Zetia ® (Ezetimibe), 2 Prozac ® (Fluoxetine) 3 and Emend ® (Aprepitant) 1 (Fig. 1).…”
Section: Introductionmentioning
confidence: 99%